S
Scott M. Grundy
Researcher at University of Texas Southwestern Medical Center
Publications - 849
Citations - 246629
Scott M. Grundy is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 187, co-authored 841 publications receiving 231821 citations. Previous affiliations of Scott M. Grundy include University of California, San Francisco & University of California, Davis.
Papers
More filters
Journal ArticleDOI
The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes.
TL;DR: The American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines recently published its 2018 recommendations on management of LDL cholesterol (LDL-C) in people with diabetes and established atherosclerotic cardiovascular disease.
Journal ArticleDOI
Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects
TL;DR: Levels of atrial natriuretic peptide in hypertrophic cardiomyopathy, a more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure.
Journal ArticleDOI
Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose.
Todd S. Perlstein,Robert R. Henry,Kieren J. Mather,Michael R. Rickels,Nicola Abate,Scott M. Grundy,Yabing Mai,Jeanine Albu,Jennifer B. Marks,James L. Pool,Mark A. Creager +10 more
TL;DR: In this article, the effects of ARB (angiotensin receptor blocker) therapy (losartan, 100 mg/day) on insulin sensitivity and endothelial function in 53 subjects with stage I hypertension, abdominal obesity and impaired fasting glucose were examined.
Journal ArticleDOI
Studied of very low density lipoprotein triglyceride metabolism in an obese population with low plasma lipids: lack of influence of body weight or plasma insulin.
Barbara V. Howard,L A Zech,Michael Davis,L. J. Bennion,P J Savage,M. Nagulesparan,D Bilheimer,P H Bennett,Scott M. Grundy +8 more
TL;DR: In this population with low plasma lipids and reduced arteriosclerotic heart disease, VLDL-TG synthesis is low, V LDL- TG catabolism is accelerated, andVLDL pools appear to be insensitive to the influence of body weight and hyperinsulinemia.
Journal ArticleDOI
Effect of Acute Alteratioris in Small Bowel Transit Time upon the Biliary Excretion Rate of Bile Acids
TL;DR: It is concluded that small bowel transit time is a major determinant of enterohepatic cycling frequency.